Applied Genetic Technologies Corporation Earning Date (AGTC)

USA |NASDAQ |USD

AGTC Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Sep 21, 2022 Jun 2022 - - $-0.28
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Sep 21, 2022 Jun 2022 - - $500.00K

Applied Genetic Technologies Corporation's next earnings date is Wednesday, Sep 21, 2022 for the fiscal quarter ending Jun 2022.

AGTC Earnings Date & History Chart

AGTC Earnings & Revenue Forecast

AGTC Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 9 $-1.53 $-1.82 $-1.17
Jun 2023 9 $-1.35 $-1.73 $-0.86

AGTC Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Jun 2022 2 / 1 $-1.40 $-1.40 $-1.64
Jun 2023 4 / 1 $-1.37 $-1.37 $-1.33

AGTC Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 8 $0.00 $0.00 $0.00
Jun 2023 8 $3.56M $0.00 $14.80M

AGTC Earnings Date & Revenue History

AGTC Earnings History

|
Show More
Show More

AGTC Revenue History

|
Show More
Show More

Applied Genetic Technologies Corporation Next Earnings Date & Report

AGTC Next Earnings Date & Report Preview: Jun 2022 (FQ)

AGTC's next earnings date is Wednesday, Sep 21, 2022 for the fiscal quarter ending Jun 30, 2022.

Applied Genetic Technologies Corporation Previous Earnings Dates & Reports

AGTC Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Applied Genetic Technologies Corporation's previous earnings date was May 16, 2022 for its fiscal quarter ended Mar 31, 2022.

AGTC Previous Earnings Date & Report Recap: Jun 2021 (FY)

Applied Genetic Technologies Corporation's previous annual earnings date was Sep 23, 2021 for its fiscal year ended Jun 30, 2021.

AGTC's earnings per share (EPS) was $-1.88, beating the consensus analysts forecast of $-1.91 by -1.57% , and higher than the previous year's EPS (Jun 2020) by -13.36%.

Revenues were $500.00K.

The company reported a net income of $-57.83M.

Applied Genetic Technologies Corporation reported a free cash flow of $-53.03M for its fiscal year, compared to $-42.82M a year ago.

The company ended the fiscal year with $24.48M in total debt, an increase of 127.02% compared to the previous year.